Pacific Biosciences Of California (PACB) Deferred Taxes (2021 - 2025)

Pacific Biosciences Of California's Deferred Taxes history runs 4 years deep, the most recent figure standing at -$546000.0 for Q1 2025.

• In Q1 2025, Deferred Taxes changed N/A year-over-year to -$546000.0; the TTM figure through Dec 2025 stood at -$546000.0 (down 166.34% YoY), while the FY2025 annual figure was -$546000.0, down 166.34% from the prior year.
• Deferred Taxes was -$546000.0 for Q1 2025 at Pacific Biosciences Of California, down from -$205000.0 in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $1.2 million in Q4 2021 to a low of -$718000.0 in Q4 2023.
• Historically, Deferred Taxes has averaged -$73500.0 across 4 years, with a median of -$375500.0 in 2024.
• Biggest YoY gain for Deferred Taxes was 71.45% in 2024; the steepest drop was 71.45% in 2024.
• A 4-year view of Deferred Taxes shows it stood at $1.2 million in 2021, then slumped by 161.11% to -$718000.0 in 2023, then surged by 71.45% to -$205000.0 in 2024, then slumped by 166.34% to -$546000.0 in 2025.
• The last three Deferred Taxes figures came in at -$546000.0 (Q1 2025), -$205000.0 (Q4 2024), and -$718000.0 (Q4 2023), per Business Quant data.